Keyphrases
Retinal pigment Epithelium
100%
Transplantation
100%
Recent Advances
100%
Age-related Macular Degeneration
100%
Stem Cell-derived
100%
Human Embryonic Stem Cells (hESCs)
50%
Cell-based
50%
Vision Loss
50%
Induced Pluripotent Stem Cells (iPSCs)
50%
Early Phase Clinical Trials
50%
Advanced Stage
25%
Anatomic
25%
Immune Response
25%
Clinical Trials
25%
Selection Criteria
25%
Neurosensory
25%
Definitive Treatment
25%
Atrophy
25%
Immunological Properties
25%
Macular Degeneration
25%
Unmet Medical Need
25%
Potential Treatments
25%
Cell Suspension
25%
Remaining Challenges
25%
Dry Form
25%
Medicine and Dentistry
Stem Cell
100%
Clinical Trial
100%
Age Related Macular Degeneration
100%
Retinal Pigment Epithelium Transplantation
100%
Human Embryonic Stem Cell
66%
Visual Impairment
66%
Induced Pluripotent Stem Cell
66%
Disease
33%
Prevalence
33%
Immune Response
33%
Cell Therapy
33%
Stem Cell Therapy
33%
Macular Degeneration
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Age Related Macular Degeneration
100%
Visual Pigment
100%
Visual Impairment
66%
Disease
33%
Prevalence
33%
Macular Degeneration
33%
Neuroscience
Stem Cell
100%
Age-Related Macular Degeneration
100%
Retinal Pigment Epithelium
100%
Embryonic Stem Cell
50%
Cell Therapy
50%
Macular Degeneration
25%